Explore our export-ready active formulas tailored to global cosmetic standards and high retail velocity.
Operating beyond intermediary brokerage: direct oversight across synthesis, stabilization, cleanroom filling, and automated packaging.
Extensive clinical and consumer-tested repository covering dermatological, clinical, and organic cosmetic matrices.
Wholly owned plants: Guangzhou Aoyan Cosmetics Co., Ltd. & Guangzhou Xinzimei Cosmetics Co., Ltd.
Long-term partnership stability supported by dedicated account management, scale economics, and rapid iteration.
Continuous operational optimization in bulk chemical processing, multi-phase emulsification, and sterile packaging.
Strategic shift toward agile manufacturing, asset-light indie brands, and customized bulk active delivery.
Global beauty conglomerates are transitioning from single-source manufacturing to hybrid global supply pipelines. China remains the undisputed epicenter for active compound synthesis, high-yield emulsification, and secondary packaging, offering an unmatchable balance between cost-efficiency and technical agility.
Consumer literacy has surged. Buyers now prioritize bioactive efficacy over legacy brand cachet. Private label brands demand rapid deployment of barrier-repair lipids, peptide complexes, and marine biopolymers, requiring manufacturers to operate as active co-research partners rather than passive bottlers.
Compliance has become the chief barrier to entry. Navigating cross-border mandates—such as MoCRA in North America and EU Regulation (EC) No 1223/2009—demands exhaustive tracing of bulk actives, standardized CPSR files, and GMP compliance at the facility level.
A unified manufacturing ecosystem engineered to mitigate risk, compress development cycles, and safeguard brand integrity.
Translating client performance briefs into bench-stable chemical matrices. Utilizing the "1+2+2+N+N" collaborative R&D framework alongside global raw material innovators to develop multi-vector anti-aging, hydration, and cleansing bases.
Seamless engineering of cosmetic vessels: airless vacuum bottles, pharmaceutical-grade amber droppers, high-barrier multilayer tubes, and FSC-certified unboxing designs with silk-screening and hot-stamping finishes.
De-risk multi-million-dollar supply commitments via calibrated small-batch pilots. Sensory profile tuning, fragrance fixation analysis, and accelerated stability indexing (45°C/75% RH over 90 days) prior to commercial runs.
Full-stack international compliance support. Production audited under GMPC, ISO 22716, and BSCI parameters. Generation of comprehensive dossiers including SDS/MSDS, Certificates of Analysis (COA), and CPNP entry assistance.
Mass-scale vacuum homogenization lines delivering batch consistency across viscosity ranges from 500 cPs (toners) to 200,000 cPs (heavy clay balms and masks), minimizing shear damage to bio-active molecules.
Export-ready palletization, container moisture management, and multimodal shipping (Ocean freight, Trans-Eurasian Rail, express air charter). Custom export clearances executed under incoterms EXW, FOB, CIF, or DDP.
Formulating specifically for regional phototypes, ambient humidity variations, and distinct consumer lifestyle behaviors.
High relative humidity and UV intensity demand ultra-matte, sweat-resistant vehicle systems. Deodorants, broad-spectrum sunscreens, and mattifying clay masks must resist phase separation and prevent pore congestion under severe ambient conditions.
Markets characterized by intense heating/cooling cycles and outdoor particulates require dense lipid barrier support. Formulations prioritize physiological lipid ratios (ceramides, cholesterol, fatty acids) to protect against trans-epidermal water loss (TEWL).
Formulations specifically calibrated for post-procedure or high-touch application. Mild surfactant washes, soothing snail secretion filtrate complexes, and bioactive under-eye hydrogel pads engineered for rapid tissue recovery without sensitization.
Continuous reinvestment into molecular biochemistry, sustainable packaging, and precision delivery platforms.
Industrial integration of postbiotics, ferment lysates, and prebiotic oligosaccharides that sustain cutaneal microflora equilibrium while extending shelf life without aggressive paraben systems.
Scaling upstream bioreactor syntheses to replace petrochemically sourced emulsifiers with yeast-derived bio-surfactants, reducing carbon output while accelerating transdermal uptake.
Sub-micron liposomal and cyclodextrin carriers targeting timed release of unstable bio-actives (e.g., L-Ascorbic Acid, Retinol) to maximize skin dwell time while eliminating irritation peaks.
Commercialization of 100% PCR resin containers, biodegradable seaweed-derived single-use mask sachet coatings, and mono-material recyclable pump dispensers to ensure total packaging circularity.
Essential guidance covering commercial boundaries, compliance prerequisites, and contract manufacturing logistics.
Bulk and OEM-ready specialized formulations built for targeted therapeutic and daily maintenance efficacy.
